| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/19/2008 | CN100434062C Application of L-2-oxathiaazalane-4-carboxylic acid and ester derivative thereof in cosmeceutical product |
| 11/18/2008 | US7453011 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
| 11/18/2008 | US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing |
| 11/18/2008 | US7453006 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
| 11/18/2008 | US7453002 Five-membered heterocycles useful as serine protease inhibitors |
| 11/18/2008 | US7452997 Tetrahydro-indazole cannabinoid modulators |
| 11/18/2008 | US7452996 Substituted quinoline derivatives |
| 11/18/2008 | US7452987 Interfering RNA molecules |
| 11/18/2008 | US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα |
| 11/18/2008 | US7452963 From 7 to 50 amino acids comprising: (1) a lysine residue six to ten residues from a second lysine residue; (2) a histidine residue; and (3) at least 6% lysine residues |
| 11/18/2008 | US7452916 Administering arginine, lysine; cardiovascular disorder therapy |
| 11/18/2008 | US7452915 Antiparasitic artemisinin derivatives (endoperoxides) |
| 11/18/2008 | US7452914 Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 11/18/2008 | US7452913 Patterns of enzyme inhibitors formed by dissolving compounds and isolation by precipitation |
| 11/18/2008 | US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/18/2008 | US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 11/18/2008 | US7452910 Reducing side effects, lowering neurotoxicity; longer lasting antitumor action |
| 11/18/2008 | US7452909 such as 2-[4-(3-chloro-phenylethynyl)-2-methyl-imidazol-1-ylmethyl]-pyridine, used for treatment and/or prevention of nervous system disorders, as anxiolytic agents and as analgesics |
| 11/18/2008 | US7452908 Amide derivatives |
| 11/18/2008 | US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 11/18/2008 | US7452906 For therapy of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy |
| 11/18/2008 | US7452905 Phenylalanine derivatives |
| 11/18/2008 | US7452904 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 11/18/2008 | US7452903 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 11/18/2008 | US7452902 Imidazopyridines as cyclin dependent kinase inhibitors |
| 11/18/2008 | US7452901 improved pharmacokinetic properties; oral bioavailibility; less side effects; novel intermediates; novel methods for synthesis; help to diagnose cancer/leukemia in vitro; inhibitors of adenosine deaminase; Purine analogues |
| 11/18/2008 | US7452900 Esters in position 20 of camptothecins |
| 11/18/2008 | US7452899 Alzheimer's disease; bridged bicycloalkyl sulphonamide and sulphamide derivatives; [9-endo]2',3', 4',5'-Tetrahydro-5'-(2.2.2-trifluoroethyl)spiro[3-{(E)-2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]ethenyl}-4-methyl bicyclo[4.2.1]non-3-ene]-9,3'-[1,2,5]thiadiazol-1',1'-dioxide |
| 11/18/2008 | US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus |
| 11/18/2008 | US7452897 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 11/18/2008 | US7452896 Pyrimidine-sulfamides and their use as endothelian receptor antagonist |
| 11/18/2008 | US7452895 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
| 11/18/2008 | US7452894 Purine derivatives as purinergic receptor antagonists |
| 11/18/2008 | US7452893 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists |
| 11/18/2008 | US7452892 2-substituted 7-aryl-[1,2,4]triazolo[4,3-c]pyrimidin-3(2H)-one; mitogen-activated protein kinase inhibitor; physiological and psychotropic effects including regulation of appetite, immunosuppression, analgesia, inflammation, emesis, anti-nocioception, sedation, and intraocular pressure |
| 11/18/2008 | US7452891 MCH antagonists and their use in the treatment of obesity |
| 11/18/2008 | US7452890 Substituted pyrazoles |
| 11/18/2008 | US7452889 e.g. 3-(2-methylbenzothiazol-5-yloxy)-1-[4-(3-phenoxypropyl)piperazinyl]propan-2-ol; fatty acid oxidation inhibitor; cardiovascular diseases: atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's angina, stable and unstable angina, and diabetes |
| 11/18/2008 | US7452888 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders |
| 11/18/2008 | US7452887 e.g. N-(4-(4-methylpiperazin-1-yl)phenyl)-6-phenylquinolin-4-amine;protein kinase A, C, G, tyrosine kinase, mitogen activated p38- alpha kinase inhibitor; tumor necrosis factor- alpha and interleukin-1 beta antagonist; antiinflammatory, anticarcinogenic; Alzheimer's disease, stroke, diabetes, obesity |
| 11/18/2008 | US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides |
| 11/18/2008 | US7452885 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation |
| 11/18/2008 | US7452884 Methods for inhibiting angiogenesis |
| 11/18/2008 | US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 11/18/2008 | US7452882 Thyroid hormone analogs |
| 11/18/2008 | US7452881 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide; serotonin receptors antagonist; anxiolytic, antidepressant, cognitive activator, senile dementia, psychosis, attention deficit/hyperactivity disorder |
| 11/18/2008 | US7452880 p38 kinase inhibitors; arthritis, Crohn's disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease; pyrazolo(3,4-d)pyrimidines |
| 11/18/2008 | US7452879 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 11/18/2008 | US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 11/18/2008 | US7452877 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent |
| 11/18/2008 | US7452876 8-Cyclohexyl-1,1a,2,12b-tetrahydro-1a-(4-morpholinylcarbonyl)-cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxylic acid, methyl ester; RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease, including cirrhosis and hepatocellular carcinoma |
| 11/18/2008 | US7452874 Thrombopoietin mimetics |
| 11/18/2008 | US7452873 Inhibitors of GSK-3 and uses thereof |
| 11/18/2008 | US7452872 Administering balsalazide with food increases bioavailability of balsalazide and metabolites 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid; label on container recommends to take drug with food; inflammatory bowel disease, radiation enteritis, colon cancer; gastrointestinal disorders |
| 11/18/2008 | US7452871 Compositions and methods for treating mammals with modified alginates and modified pectins |
| 11/18/2008 | US7452870 Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| 11/18/2008 | US7452861 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 11/18/2008 | US7452717 Carboxylesterase; antitumor agents; drug screening; bioassay |
| 11/18/2008 | US7452680 MCT1 transporters expressed in blood brain barrier cells |
| 11/18/2008 | US7452556 Compositions for the treatment of pilosebaceous gland inflammations comprising aluminum fluoride |
| 11/18/2008 | US7452555 Cocrystallization |
| 11/18/2008 | US7452553 Dietary fiber delivery system |
| 11/18/2008 | US7452549 A source of delta-tocotrienol and/or-tocopherol acts synergistically with an antioxidant source comprising polyphenols, to effect suppression of LDL oxidation in serum. The combination of these two antioxidant sources has |
| 11/18/2008 | US7452548 Conjugated linoleic acid compositions |
| 11/18/2008 | US7452545 Protective and healing effects for skin, hair, nails and mucous membranes |
| 11/18/2008 | US7452534 low antigenicity, reduced (or absent) T cell depleting activity, good affinity to human CD4 and enhanced stability (in vivo half-life); chimeric antibodies contain Old World monkey variable sequences and human constant domain sequences |
| 11/18/2008 | US7452527 Administering to a patient a sugar compound that is converted to a glycosaminoglycan in the patient; a primary antioxidant component; at least one amino acid component; and at least one transition metal component for promating hair growth |
| 11/18/2008 | US7452525 demonstrates excellent adhesion to hair; significantly less or no flaking at all; provides improved humidity retention, higher luster and natural feel |
| 11/18/2008 | US7452373 Stent coated with magnesium-based compound for reducing thrombosis |
| 11/18/2008 | CA2589613A1 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| 11/18/2008 | CA2587127C Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids |
| 11/18/2008 | CA2523831C 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension |
| 11/18/2008 | CA2519252C Biaryl substituted triazoles as sodium channel blockers |
| 11/18/2008 | CA2517141C Method to produce a solid form of heparin |
| 11/18/2008 | CA2516557C Triazole compounds useful in therapy |
| 11/18/2008 | CA2493704C Platinum complexes containing chemically modified bile acids, having antitumor activity |
| 11/18/2008 | CA2469369C Compositions containing both sedative and non-sedative antihistamines |
| 11/18/2008 | CA2462572C Tetracycline derivatives and methods of use thereof |
| 11/18/2008 | CA2455539C Pig growth enhancer and pig growth enhancing method |
| 11/18/2008 | CA2452530C Novel immunosuppressive agent |
| 11/18/2008 | CA2440222C Triazolopyridines as anti-inflammatory agents |
| 11/18/2008 | CA2435613C An anti-atherosclerosis composition containing carotenoids and method for inhibiting ldl oxidation |
| 11/18/2008 | CA2434682C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 11/18/2008 | CA2423659C Antiviral composition and treatment method |
| 11/18/2008 | CA2422379C Pyrazole compounds useful as protein kinase inhibitors |
| 11/18/2008 | CA2417500C Erbb-2 selective small molecule kinase inhibitors |
| 11/18/2008 | CA2416147C Dermal application system for aminolevulinic acid |
| 11/18/2008 | CA2415840C Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 11/18/2008 | CA2413163C 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides |
| 11/18/2008 | CA2411966C Compositions for treating or preventing malaria and method of treating malaria |
| 11/18/2008 | CA2406846C Pharmacotherapeutic process and composition for central nervous system disorders |
| 11/18/2008 | CA2402652C Viscoelastics for use in middle ear surgery |
| 11/18/2008 | CA2397537C External plaster containing 4-biphenylyl acetic acid |
| 11/18/2008 | CA2395481C Hormone receptor modulation |
| 11/18/2008 | CA2385986C New use of modafinil and the d/l enantiomers for enhancing sexual function in mammals |
| 11/18/2008 | CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 11/18/2008 | CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 11/18/2008 | CA2376202C Novel preparation and administration form comprising an acid-labile active compound |
| 11/18/2008 | CA2375743C Methods and compositions for the support, regeneration and repair of connective tissues |
| 11/18/2008 | CA2362281C Combinations for the treatment of diseases involving angiogenesis |